US Patent Issued to Keros Therapeutics on Jan. 13 for "Activin receptor type II chimeras and methods of use thereof" (American, Danish Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,646, issued on Jan. 13, was assigned to Keros Therapeutics Inc. (Lexington, Mass.).

"Activin receptor type II chimeras and methods of use thereof" was invented by Jasbir S. Seehra (Lexington, Mass.), Jennifer Lachey (Lincoln, Mass.), Claire Tseng (Newton, Mass.), Jason O'Neill (Lake Forest Park, Wash.) and Henning Thogersen (Farum, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention features polypeptides that include an extracellular ActRII chimera. In some embodiments, a polypeptide of the invention includes an extracellular ActRII chimera fused to an Fc domain monomer or moiety. The invention also features pharmaceutical compositi...